290 related articles for article (PubMed ID: 31351252)
21. Ablation of Perlecan Domain 1 Heparan Sulfate Reduces Progressive Cartilage Degradation, Synovitis, and Osteophyte Size in a Preclinical Model of Posttraumatic Osteoarthritis.
Shu CC; Jackson MT; Smith MM; Smith SM; Penm S; Lord MS; Whitelock JM; Little CB; Melrose J
Arthritis Rheumatol; 2016 Apr; 68(4):868-79. PubMed ID: 26636652
[TBL] [Abstract][Full Text] [Related]
22. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
Vischer P; Feitsma K; Schön P; Völker W
Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
[TBL] [Abstract][Full Text] [Related]
23. Perlecan heparan sulfate deficiency impairs pulmonary vascular development and attenuates hypoxic pulmonary hypertension.
Chang YT; Tseng CN; Tannenberg P; Eriksson L; Yuan K; de Jesus Perez VA; Lundberg J; Lengquist M; Botusan IR; Catrina SB; Tran PK; Hedin U; Tran-Lundmark K
Cardiovasc Res; 2015 Jul; 107(1):20-31. PubMed ID: 25952902
[TBL] [Abstract][Full Text] [Related]
24. Heparan and chondroitin sulfate on growth plate perlecan mediate binding and delivery of FGF-2 to FGF receptors.
Smith SM; West LA; Govindraj P; Zhang X; Ornitz DM; Hassell JR
Matrix Biol; 2007 Apr; 26(3):175-84. PubMed ID: 17169545
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional activation by NFκB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironment.
Warren CR; Grindel BJ; Francis L; Carson DD; Farach-Carson MC
J Cell Biochem; 2014 Jul; 115(7):1322-33. PubMed ID: 24700612
[TBL] [Abstract][Full Text] [Related]
26. Impaired angiogenesis, delayed wound healing and retarded tumor growth in perlecan heparan sulfate-deficient mice.
Zhou Z; Wang J; Cao R; Morita H; Soininen R; Chan KM; Liu B; Cao Y; Tryggvason K
Cancer Res; 2004 Jul; 64(14):4699-702. PubMed ID: 15256433
[TBL] [Abstract][Full Text] [Related]
27. Increased intimal hyperplasia and smooth muscle cell proliferation in transgenic mice with heparan sulfate-deficient perlecan.
Tran PK; Tran-Lundmark K; Soininen R; Tryggvason K; Thyberg J; Hedin U
Circ Res; 2004 Mar; 94(4):550-8. PubMed ID: 14739157
[TBL] [Abstract][Full Text] [Related]
28. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.
Brown JC; Sasaki T; Göhring W; Yamada Y; Timpl R
Eur J Biochem; 1997 Nov; 250(1):39-46. PubMed ID: 9431988
[TBL] [Abstract][Full Text] [Related]
29. Primary Salivary Human Stem/Progenitor Cells Undergo Microenvironment-Driven Acinar-Like Differentiation in Hyaluronate Hydrogel Culture.
Srinivasan PP; Patel VN; Liu S; Harrington DA; Hoffman MP; Jia X; Witt RL; Farach-Carson MC; Pradhan-Bhatt S
Stem Cells Transl Med; 2017 Jan; 6(1):110-120. PubMed ID: 28170182
[TBL] [Abstract][Full Text] [Related]
30. RGDSP-Decorated Hyaluronate Hydrogels Facilitate Rapid 3D Expansion of Amylase-Expressing Salivary Gland Progenitor Cells.
Fowler EW; Ravikrishnan A; Witt RL; Pradhan-Bhatt S; Jia X
ACS Biomater Sci Eng; 2021 Dec; 7(12):5749-5761. PubMed ID: 34781679
[No Abstract] [Full Text] [Related]
31. Comparison of the effects of class 1 and class 2 heparin-binding growth factors on protein synthesis and actin mRNA expression in BALB/c-3T3 cells.
Rybak SM; Lobb RR; Fett JW
J Cell Physiol; 1988 Aug; 136(2):312-8. PubMed ID: 2457594
[TBL] [Abstract][Full Text] [Related]
32. Altered stress induced by partial transection of the infraspinatus tendon leads to perlecan (HSPG2) accumulation in an ovine model of tendinopathy.
Melrose J; Smith MM; Smith SM; Ravi V; Young AA; Dart AJ; Sonnabend DH; Little CB
Tissue Cell; 2013 Feb; 45(1):77-82. PubMed ID: 23245384
[TBL] [Abstract][Full Text] [Related]
33. Nephronectin binds to heparan sulfate proteoglycans via its MAM domain.
Sato Y; Shimono C; Li S; Nakano I; Norioka N; Sugiura N; Kimata K; Yamada M; Sekiguchi K
Matrix Biol; 2013 Apr; 32(3-4):188-95. PubMed ID: 23357641
[TBL] [Abstract][Full Text] [Related]
34. Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer's disease, accelerates A beta fibril formation, and maintains A beta fibril stability.
Castillo GM; Ngo C; Cummings J; Wight TN; Snow AD
J Neurochem; 1997 Dec; 69(6):2452-65. PubMed ID: 9375678
[TBL] [Abstract][Full Text] [Related]
35. Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer's disease.
Snow AD; Kinsella MG; Parks E; Sekiguchi RT; Miller JD; Kimata K; Wight TN
Arch Biochem Biophys; 1995 Jun; 320(1):84-95. PubMed ID: 7793988
[TBL] [Abstract][Full Text] [Related]
36. Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue.
Burgess WH; Shaheen AM; Ravera M; Jaye M; Donohue PJ; Winkles JA
J Cell Biol; 1990 Nov; 111(5 Pt 1):2129-38. PubMed ID: 1699952
[TBL] [Abstract][Full Text] [Related]
37. Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior.
Grindel BJ; Martinez JR; Pennington CL; Muldoon M; Stave J; Chung LW; Farach-Carson MC
Matrix Biol; 2014 Jun; 36():64-76. PubMed ID: 24833109
[TBL] [Abstract][Full Text] [Related]
38. Mechanical Properties and Cell Compatibility of Agarose Hydrogels Containing Proteoglycan Mimetic Graft Copolymers.
Pauly HM; Place LW; Haut Donahue TL; Kipper MJ
Biomacromolecules; 2017 Jul; 18(7):2220-2229. PubMed ID: 28618228
[TBL] [Abstract][Full Text] [Related]
39. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.
Qiang B; Lim SY; Lekas M; Kuliszewski MA; Wolff R; Osherov AB; Rudenko D; Leong-Poi H; Noyan H; Husain M; Tran K; Tryggvason K; Hedin U; Tran-Lundmark K; Strauss BH
Can J Cardiol; 2014 Nov; 30(11):1444-51. PubMed ID: 25249499
[TBL] [Abstract][Full Text] [Related]
40. Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells.
Whitelock JM; Graham LD; Melrose J; Murdoch AD; Iozzo RV; Underwood PA
Matrix Biol; 1999 Apr; 18(2):163-78. PubMed ID: 10372557
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]